Fig. 4From: Point-of-care detection of Neisseria gonorrhoeae based on RPA-CRISPR/Cas12aClinical validation. a Clinical validation of the RPA-Cas12a-fluorescent assay. 24 clinical samples from individuals suspected of having gonorrhea were examined by the RPA-Cas12a-fluorescent assay. AU, arbitrary unit. b Clinical validation of the RPA-Cas12a-LFD assay. 24 clinical samples from individuals suspected of having gonorrhea were examined by the RPA-Cas12a-LFD assayBack to article page